Clinical Trial Update: [68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating [68Ga]Ga-PentixaFor PET imaging for staging Marginal Zone Lymphoma has been terminated; sponsor Pentixapharm AG reported the TERMINATED…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Drugs mentioned

• [68Ga]Ga-PentixaFor (pentixaFor radiopharmaceutical)

Snippet

Sponsor: Pentixapharm AG | Conditions: Marginal Zone Lymphoma | Phase 3 | Status: TERMINATED